How Much Does Zepbound Cost? The Pen, the Vial, and the Reason They Are Priced Differently

Trust signals

> Reviewed by FormBlends Medical Team · Last updated September 5, 2026 · 27 sources cited · Prices checked September 4 to 5, 2026; confirm current pricing directly with the pharmacy or manufacturer.

Key Takeaways

• Zepbound single-dose pens carry a list price of $499 to $1,086 per 28 days and averaged $1,291.34 a month at retail with no offer; KwikPens and vials averaged $599.85 (GoodRx, updated May 18, 2026)
• LillyDirect sells the vial or the KwikPen for $299 (2.5 mg), $399 (5 mg) and $449 (7.5 to 15 mg) a month when you refill within 45 days, otherwise $499 or $699 (lilly.com, September 4, 2026); the $349 to $499 ladder printed here earlier was the October 2025 launch pricing
• With commercial insurance that covers Zepbound, the Lilly savings card brings the copay to as little as $25, with savings capped at $100, $200 and $300 per 1-, 2- and 3-month fill, $1,300 a year and 13 fills, through December 31, 2026; if your commercial plan excludes Zepbound the same program sells it for $499
• Medicare changed on July 1, 2026: the GLP-1 Bridge covers the Zepbound KwikPen for obesity at a $50 monthly copay through December 31, 2027 for enrollees meeting BMI criteria without type 2 diabetes; the OSA indication remains a regular Part D route
• The vial format requires comfort with syringe administration, a tradeoff for the lower price

Direct answer

As of September 4, 2026, Zepbound has four prices. Cash through LillyDirect: $299 a month at 2.5 mg, $399 at 5 mg, $449 at 7.5 mg and above, as a single-dose vial or a KwikPen, as long as you refill within 45 days (otherwise $499 or $699). Commercial insurance that covers it: as little as $25 with the savings card ($100 to $300 savings caps, $1,300 a year), or $499 if your commercial plan excludes it. Medicare: $50 a month for the KwikPen through the GLP-1 Bridge that began July 1, 2026, if you meet its BMI criteria. Retail with no offer: about $1,291 a month for single-dose pens (GoodRx, May 18, 2026), which almost nobody should pay. Confirm current pricing directly with Lilly or your pharmacy.

Table of contents

1. The two Zepbound channels: pen vs. vial
2. Pen pricing at U.S. retail
3. Lilly Direct vial pricing in detail
4. What insurance pays for Zepbound
5. The Lilly savings card mechanics
6. Lilly Cares patient assistance
7. Pen vs. vial: which makes sense for which patient
8. Zepbound for sleep apnea: Medicare's narrow door
9. How Zepbound pricing compares across the GLP-1 class
10. The decision framework
11. LillyDirect price ladder and the 45-day rule
12. Retail vs list vs LillyDirect
13. Savings card math (current terms)
14. Medicare: $50 KwikPen under the GLP-1 Bridge
15. First-year cost scenarios (2026)
16. How Zepbound compares across the class
17. FAQ
18. Sources

The two Zepbound channels: pen vs. vial

Zepbound launched in late 2023 in single-dose autoinjector pen form at traditional retail pricing. In 2024 Eli Lilly opened LillyDirect, a manufacturer-operated cash-pay channel that first shipped single-dose vials and now also sells a multi-dose KwikPen at the same self-pay price; since October 29, 2025 the same pricing has been available for pickup at Walmart pharmacies. The channels deliver the same active drug (tirzepatide) at very different prices: single-dose pens through insurance or at retail, vials and KwikPens for cash.

The split is deliberate. Pens are convenient but expensive to manufacture. Vials are cheaper to produce but require the patient to draw the dose into a syringe and inject it manually. By offering both, Lilly captures patients across the willingness-to-pay spectrum without lowering the headline pen price.

Pen pricing at U.S. retail

Zepbound's list price runs $499 to $1,086 per 28-day supply depending on the form (GoodRx, as of January 2026; Ro's cost article of June 26, 2026 gives $1,086.37 for single-dose pens). What pharmacies actually charge without an offer is higher: GoodRx's average retail price was $1,291.34 for single-dose pens and $599.85 for KwikPens and vials as of May 18, 2026, and Ro quotes Costco at $1,078.79. The $1,059 figure printed here earlier is out of date.

The pen comes as a single-use autoinjector containing one weekly dose. A one-month supply is four pens. Each dose strength (2.5, 5, 7.5, 10, 12.5, 15 mg) is a different pen; you cannot dial in a custom dose. Cash retail does not vary meaningfully across pen strengths.

Lilly Direct vial pricing in detail

The LillyDirect program targets self-pay patients who do not have insurance coverage for Zepbound or who do not want to use insurance. Pricing as of September 4, 2026, for a single-dose vial or a KwikPen:

Dose	Lilly Direct monthly price	Format
2.5 mg	$299	4 single-dose vials, 1 per week, or 1 KwikPen
5 mg	$399	4 single-dose vials, 1 per week, or 1 KwikPen
7.5 mg	$449 with a refill within 45 days; otherwise $499 or $699	4 single-dose vials, 1 per week, or 1 KwikPen
10 mg	$449 with a refill within 45 days; otherwise $499 or $699	4 single-dose vials, 1 per week, or 1 KwikPen
12.5 mg	$449 with a refill within 45 days; otherwise $499 or $699	4 single-dose vials, 1 per week, or 1 KwikPen
15 mg	$449 with a refill within 45 days; otherwise $499 or $699	4 single-dose vials, 1 per week, or 1 KwikPen

The order includes syringes and needles. Shipping is free for monthly orders. Patients order through the Lilly Direct portal after a prescriber writes the prescription specifically for the vial product, which uses a different NDC than the pen.

LillyDirect pricing is available by home delivery or by pickup at Walmart pharmacies (Walmart release, October 29, 2025), and GoodRx (May 18, 2026) lists the $299 KwikPen manufacturer offer at Walgreens, CVS, Walmart, Costco, Sam's Club and Target. The one rule that trips people up is the 45-day window: WeightWatchers' Zepbound page and Honest Care (April 2026) both print dose-specific fallback prices of $599 (7.5 mg), $699 (10 mg), $849 (12.5 mg) and $1,049 (15 mg) for a fill outside 45 days, while Lilly's own page summarizes the fallback as $499 or $699. Either way, a late refill costs $50 to $600 more.

What insurance pays for Zepbound

Commercial insurance coverage for Zepbound has improved meaningfully since the obstructive sleep apnea indication was added in 2024 and the SURMOUNT-4 maintenance data was published. Coverage status depends on the employer plan design more than on the insurer; the same Blue Cross plan can include or exclude Zepbound depending on the group.

When a plan covers Zepbound:

• Preferred-brand tier copay: typically $40 to $80 monthly
• Non-preferred-brand tier copay: typically $80 to $200 monthly
• High-deductible plan: full negotiated rate (roughly $700 to $900) until deductible is met
• Specialty tier or coinsurance: variable, sometimes 20 to 40 percent of negotiated rate

Prior authorization is nearly universal. UnitedHealthcare's commercial policy effective September 1, 2026 is a public example: age over 16, BMI 30 or higher or 27 with a comorbidity such as dyslipidemia, hypertension, type 2 diabetes or sleep apnea, use alongside lifestyle modification, a 6-month initial approval, and renewal for 12 months once you have lost at least 5 percent of baseline weight.

The Lilly savings card mechanics

The Zepbound Savings Card for commercially insured patients works as follows as of September 4, 2026 (program expires December 31, 2026):

Scenario	Cost after card
Insurance covers Zepbound	As little as $25; savings capped at $100 per 1-month fill, $200 per 2-month fill, $300 per 3-month fill; $1,300 a year; 13 fills
Insurance does not cover Zepbound	$499 for a 1-month supply through the same program (the $650 figure printed here earlier is out of date)
Medicare, Medicaid, TRICARE, VA	Not eligible
Uninsured	Not eligible; use LillyDirect vials or KwikPens at $299 to $449

The card stacks on top of commercial insurance benefits. For uninsured cash patients, the relevant program is Lilly Direct, not the savings card.

Lilly Cares patient assistance

Correction, September 2026: an earlier version of this section stated that the Lilly Cares Foundation provides Zepbound free to qualifying patients and listed eligibility rules and an approval timeline. Which products Lilly Cares covers changes, and we do not assert here whether Zepbound is currently included; check lillycares.com directly. For orientation only:

• Lilly Cares is a charitable program separate from the savings card and from LillyDirect
• Many manufacturer assistance programs use a multiple of the HHS poverty guideline; 400 percent of the 2026 guideline is $63,840 for one person and $132,000 for a family of four (HHS ASPE)
• Medicare enrollees have a program built for them: the GLP-1 Bridge at $50 a month for the KwikPen (July 1, 2026 to December 31, 2027)
• Uninsured patients who do not qualify for any assistance have LillyDirect at $299 to $449 as the manufacturer's cash route

We no longer print an approval timeline for Lilly Cares because we could not verify one. LillyDirect at $299 to $449 is the immediate option while any application is pending.

Pen vs. vial: which makes sense for which patient

The choice is not purely financial. The pen and vial differ in user experience:

Factor	Pen	Vial
Monthly cash cost (September 2026)	$1,291.34 average retail with no offer (GoodRx, May 18, 2026)	$299 to $449 through LillyDirect (vial or KwikPen), with the 45-day refill rule
Insurance compatibility	Standard claims processing; the insurable form	Cash-only formats (vials and KwikPens are not billed to insurance, per WeightWatchers' Zepbound page)
Injection technique	Autoinjector, push button	Draw from vial into syringe
Suitable for first-time self-injectors	Yes, easier learning curve	Possible, requires technique training
Travel convenience	Compact, prefilled	Requires vial, syringe, alcohol swab
Dose flexibility	None; fixed by pen strength	None; fixed by vial concentration
Disposal	Pen body in sharps	Vial and used syringe in sharps

For insured patients paying a $25 copay with the savings card, the single-dose pen is the better experience for no extra cost. For cash patients, the vial or KwikPen at $299 to $449 saves roughly $840 to $990 a month against the $1,291.34 average retail price for pens, and the KwikPen removes the syringe objection entirely.

Zepbound for sleep apnea: Medicare's narrow door

The FDA added moderate to severe obstructive sleep apnea in adults with obesity as a Zepbound indication on December 20, 2024, based on the SURMOUNT-OSA trials (469 adults, 52 weeks). This mattered for Medicare patients because Part D is prohibited from covering drugs for weight loss alone but can cover them for other indications. Since July 1, 2026 the door is no longer narrow: the Medicare GLP-1 Bridge covers the Zepbound KwikPen for obesity itself at $50 a month (details in the new Medicare section below), and the OSA route remains available through regular Part D for patients the Bridge excludes.

Patients with documented OSA and obesity may now have a path to Medicare coverage that did not exist before. Plan formularies and prior authorization criteria vary widely. The OSA pathway typically requires:

• Polysomnography demonstrating moderate or severe OSA (AHI 15 or higher)
• BMI 30 or greater
• Prescriber documentation of OSA as the primary indication

Patients pursuing this path should expect prior authorization. Some plans deny the first request and approve on appeal with sleep study documentation attached.

How Zepbound pricing compares across the GLP-1 class

Drug	Approx. monthly cash retail with no offer (date in cell)	Manufacturer cash-pay alternative (seen September 4, 2026)
Zepbound (tirzepatide)	$1,291.34 for single-dose pens; $599.85 for KwikPens and vials (GoodRx, May 18, 2026)	LillyDirect vial or KwikPen $299, $399, $449 with the 45-day rule
Wegovy (semaglutide)	About $1,639 (GoodRx, September 4, 2026)	NovoCare Pharmacy: pen $199 for a new patient's first two fills then $349; Wegovy HD $399; pill $149, $199, $299
Mounjaro (tirzepatide)	$1,112.16 list; $1,351.69 GoodRx average retail (September 5, 2026)	$499 through Lilly's program only if a commercial plan excludes it; savings card $25 with $150, $300, $450 caps
Ozempic (semaglutide)	$998 (May 2026 figure, not re-verified in September 2026)	NovoCare Pharmacy self-pay program exists; see our Ozempic cost guide for current terms
Saxenda (liraglutide)	~$1,200 (May 2026 figure, not re-verified in September 2026)	Generic liraglutide is now available; see our liraglutide price guide

Novo Nordisk has matched Lilly's move: the Wegovy pen is $199 for two fills then $349 and the pill starts at $149, so semaglutide is now cheaper than Zepbound at the starting doses, while Zepbound's $449 top tier undercuts Wegovy's $349 only if you count the higher trial weight loss per dollar. Compounded tirzepatide sat at a $299 month-one median across 14 telehealth providers in the Compounded GLP-1 Price Index on September 3, 2026, the same as LillyDirect's 2.5 mg price.

The decision framework

If you have commercial insurance that covers Zepbound: use the pen with the Lilly savings card. Most patients pay $25 to $80 monthly.

If you have commercial insurance that does not cover Zepbound: the savings program sells a 1-month supply for $499, but LillyDirect at $299 to $449 is cheaper at every dose as long as you refill within 45 days.

If you have Medicare with OSA and obesity: pursue coverage under the OSA indication. If denied, Lilly Direct vials are the fallback.

If you have Medicare without OSA: since July 1, 2026 the GLP-1 Bridge covers the KwikPen at $50 a month if your BMI is 35 or higher, or 30 or 27 with the listed conditions, and you do not have type 2 diabetes. If you do not meet those criteria, LillyDirect at $299 to $449 is the cash option.

If you are uninsured: LillyDirect at $299 to $449 is the manufacturer's cash route. Check lillycares.com yourself for whether any charitable program currently applies; we do not assert that it does.

If self-injection from a vial is not workable: the pen is worth the premium. Patients with manual dexterity issues, vision impairment, or strong needle aversion often find the vial difficult.

LillyDirect Zepbound price ladder (September 2026) and the 45-day rule

Lilly's own page is the authority for the base prices; the fallback prices for a late refill are printed differently by Lilly ($499 or $699) and by two resellers that publish a dose-by-dose schedule. Both are shown.

Dose	LillyDirect price with a refill within 45 days (Lilly, September 4, 2026)	Fill outside 45 days	Approximate saving vs $1,086 list (Honest Care, April 2026)
2.5 mg	$299	not applicable at the starting dose	about 72 percent
5 mg	$399	$499 per Lilly	about 63 percent
7.5 mg	$449	$499 or $699 per Lilly; $599 per WeightWatchers and Honest Care	about 59 percent
10 mg	$449	$699 per Lilly, WeightWatchers and Honest Care	about 59 percent
12.5 mg	$449	$699 per Lilly; $849 per WeightWatchers and Honest Care	about 59 percent
15 mg	$449	$699 per Lilly; $1,049 per WeightWatchers and Honest Care	about 59 percent

The 45 days run from your previous fill, not from your last injection. WeightWatchers' Zepbound page adds a detail that matters for insured patients: vials and KwikPens are cash-only formats, while single-dose pens are the form that insurance covers.

Retail vs list vs LillyDirect: GoodRx's May 2026 numbers

Channel (source and date)	Price
List price, single-dose pens (GoodRx, as of January 2026; Ro, June 26, 2026)	$499 to $1,086.37 per 28 days
Average retail, single-dose pens, no offer (GoodRx, May 18, 2026)	$1,291.34
Average retail, KwikPens and vials, no offer (GoodRx, May 18, 2026)	$599.85
Costco cash price, single-dose pens (Ro, June 26, 2026)	$1,078.79 in store; $1,081.79 delivery
KwikPen with the Lilly offer at retail (GoodRx, May 18, 2026)	$299 at Walgreens, CVS, Walmart, Costco, Sam's Club and Target
LillyDirect delivery or Walmart pickup (Lilly, September 4, 2026)	$299, $399, $449 by dose

Two forms, two markets. Single-dose pens are what insurers cover and what retail quotes reflect; vials and KwikPens exist mainly for the cash channel, which is why their average retail is less than half the pen figure even before the Lilly offer.

Savings card math that matches the current card

Situation (zepbound.lilly.com, September 4, 2026)	You pay	Program limit
Commercial plan covers Zepbound, 1-month fill	As little as $25	Maximum savings $100 per fill
Commercial plan covers Zepbound, 2-month fill	As little as $25	Maximum savings $200
Commercial plan covers Zepbound, 3-month fill	As little as $25	Maximum savings $300
Annual limit		$1,300 in savings and 13 fills per calendar year
Commercial plan does not cover Zepbound	$499 for a 1-month supply	Same program, same expiry
Program end		December 31, 2026
Medicare, Medicaid, TRICARE, VA	Not eligible	Medicare enrollees: $50 GLP-1 Bridge instead

The cap matters in the deductible phase: if your plan covers Zepbound but you have not met a high deductible, the card knocks at most $100 off a 1-month fill, so LillyDirect's $299 to $449 cash price can be cheaper until the deductible is met.

Medicare: $50 Zepbound KwikPen under the GLP-1 Bridge (July 1, 2026 to December 31, 2027)

This is the change that made the earlier version of this article wrong about Medicare. CMS launched the Medicare GLP-1 Bridge on July 1, 2026 (CMS provider page, last updated August 6, 2026; Lilly's Zepbound Medicare page).

Bridge rule (CMS, last updated August 6, 2026)	Detail
Dates	July 1, 2026 through December 31, 2027
Copay	$50 per 30-day supply; the copay does not count toward the Part D deductible or the $2,100 out-of-pocket cap
Drugs	Wegovy pen and pill, Zepbound KwikPen only (not single-dose pens or vials), Foundayo
Who qualifies	BMI 35 or higher; or BMI 30 or higher with heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease stage 3a or worse; or BMI 27 or higher with prediabetes, prior heart attack, prior stroke, or symptomatic peripheral artery disease
Who is excluded	People with type 2 diabetes, moderate to severe obstructive sleep apnea, or MASH use regular Part D coverage instead
Prior authorization	Pharmacy transmits the request within 24 to 72 hours; decision within 72 hours; no appeals, but a corrected request can be resubmitted; approval is valid through December 31, 2027 for refills and dose changes

Only the KwikPen is covered; single-dose pens and vials are not. Prior authorization happens at the first fill, and Lilly's Medicare page lists the claim details pharmacies use. Medicare patients with type 2 diabetes are excluded and are routed to Mounjaro under regular Part D; patients with OSA use the OSA indication under regular Part D.

First-year cost scenarios (2026)

First-year scenario (prices as of September 4, 2026)	Arithmetic	Year-one total
LillyDirect, 2.5 mg then 5 mg then 7.5 mg or higher, every refill within 45 days	$299 + $399 + 10 x $449	$5,188
Retail single-dose pens, no offer, 13 fills	13 x $1,291.34	about $16,787
Commercial insurance that covers Zepbound, with the savings card	12 x $25 (savings stay within the $1,300 annual cap)	$300
Commercial plan excludes Zepbound, savings program price	12 x $499	$5,988
Medicare GLP-1 Bridge	12 x $50	$600
Compounded tirzepatide at the 14-provider median (FormBlends price index, September 3, 2026)	12 x $299	$3,588

The retail row exists to show what nobody should pay. Every other row is a real 2026 route, and the spread between them, $300 to $5,988, is entirely about which program you qualify for, not about the drug.

How Zepbound compares across the class, dated

Drug (checked September 4 to 5, 2026)	Retail with no offer	Manufacturer self-pay	With commercial coverage
Zepbound (tirzepatide)	$1,291.34 pens; $599.85 KwikPens and vials (GoodRx, May 18, 2026)	$299, $399, $449 (LillyDirect, 45-day rule)	As little as $25; $499 if excluded
Mounjaro (tirzepatide)	$1,112.16 list; $1,351.69 GoodRx average	None; $499 only if a commercial plan excludes it	As little as $25 with $150, $300, $450 caps
Wegovy (semaglutide)	About $1,639 (GoodRx)	Pen $199 for the first two fills then $349; HD $399; pill $149, $199, $299	As little as $25, $100 monthly maximum savings
Compounded tirzepatide (not FDA-approved)	not applicable	$299 month-one median, range $149 to $470 (price index, September 3, 2026)	Not covered
Compounded semaglutide (not FDA-approved)	not applicable	$197 month-one median, $224 month four (same index)	Not covered

FDA had logged more than 730 adverse-event reports for compounded tirzepatide and 990 for compounded semaglutide as of May 31, 2026. FormBlends sells compounded products and appears as a row in the Compounded GLP-1 Price Index under the same rules as every other provider; our current price is on the product page.

FAQ

How much does Zepbound cost in 2026?

As of September 4, 2026: $299, $399 or $449 a month through LillyDirect (vial or KwikPen, refill within 45 days), as little as $25 with the savings card if commercial insurance covers it, $499 if a commercial plan excludes it, $50 a month on Medicare's GLP-1 Bridge for eligible enrollees, and about $1,291 a month for single-dose pens at retail with no offer (GoodRx, May 18, 2026).

What is Lilly Direct and how does it compare to retail Zepbound?

LillyDirect is Eli Lilly's manufacturer-direct cash-pay program. It sells Zepbound as a single-dose vial or a KwikPen for $299 (2.5 mg), $399 (5 mg) or $449 (7.5 to 15 mg) a month with a refill within 45 days, by home delivery or Walmart pickup, against an average retail price of $1,291.34 for single-dose pens with no offer (GoodRx, May 18, 2026).

Why are Lilly Direct vials cheaper than the pen?

Vials are less expensive to manufacture and ship. Direct-to-consumer sale removes pharmacy intermediary costs.

Does insurance cover Zepbound and what does it cost with coverage?

Coverage has expanded since the 2023 FDA approval. Copays typically run $25 to $200 monthly depending on tier; the savings card can lower to $25.

What dose strengths of Zepbound are available?

2.5, 5, 7.5, 10, 12.5, and 15 mg weekly. The 2.5 mg dose is for titration only.

Is Zepbound cheaper than Wegovy?

At retail with no offer, yes: about $1,291 for Zepbound pens versus about $1,639 for Wegovy (GoodRx). On manufacturer self-pay it is the reverse at the start: Wegovy is $199 a month for a new patient's first two fills then $349, while Zepbound is $299, $399 then $449. With commercial insurance both savings cards reach $25, and Medicare's Bridge prices both at $50.

Does Medicare cover Zepbound?

Since July 1, 2026, yes for obesity itself through the Medicare GLP-1 Bridge: the KwikPen costs $50 a month through December 31, 2027 for enrollees with a BMI of 35 or higher, or 30 or 27 with specific conditions, excluding people with type 2 diabetes, sleep apnea or MASH (CMS, August 6, 2026). The obstructive sleep apnea indication remains a separate route through regular Part D.

How much does a Zepbound vial last?

One vial is one weekly dose. The monthly Lilly Direct order ships four vials.

Can I use the Lilly Direct vials at home if I've only used pens before?

Yes, with technique training. Patients uncomfortable with syringes may prefer the pen.

Will Zepbound get cheaper over time?

It already has. LillyDirect vials launched at Walmart on October 29, 2025 at $349 and $499; by December 2025 the ladder was $299, $399 and $449 for vials and KwikPens, and those prices held through September 4, 2026 with program terms posted through December 31, 2026. Retail pen pricing has not fallen. Generic tirzepatide is years away.

Are there compounded tirzepatide alternatives to Zepbound?

Yes. Compounded tirzepatide is prepared by 503A pharmacies on individual prescriptions, is not FDA-approved or reviewed for safety or effectiveness, and is not interchangeable with Zepbound. In the FormBlends Compounded GLP-1 Price Index (September 3, 2026) the month-one median across 14 telehealth providers was $299 (range $149 to $470) and the month-four median $299, so it now costs about the same as LillyDirect's 2.5 mg price.

How much does Zepbound cost without insurance in 2026?

Through LillyDirect, $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5, 10, 12.5 or 15 mg, as a vial or KwikPen, when you refill within 45 days; a late fill is $499 or $699 per Lilly (resellers list $599 to $1,049 by dose). At a retail pharmacy with no offer, GoodRx's average was $1,291.34 for single-dose pens and $599.85 for KwikPens and vials (May 18, 2026). Prices checked September 4, 2026.

How much does Zepbound cost with insurance?

If a commercial plan covers it, the Lilly savings card brings the copay to as little as $25, with savings capped at $100 per 1-month fill, $200 per 2-month fill and $300 per 3-month fill, up to $1,300 and 13 fills a year, through December 31, 2026. If your commercial plan excludes Zepbound, the same program sells a month for $499. Medicare enrollees who meet the GLP-1 Bridge criteria pay $50 a month for the KwikPen (July 1, 2026 to December 31, 2027).

Is LillyDirect self-pay Zepbound $350 or $650?

Neither, as of September 4, 2026. Lilly's page lists $299 for 2.5 mg, $399 for 5 mg and $449 for every dose from 7.5 to 15 mg, provided you refill within 45 days of your previous fill. Outside that window Lilly quotes $499 or $699, and WeightWatchers and Honest Care print dose-specific fallbacks of $599, $699, $849 and $1,049. The $349 and $499 prices people remember were the October 29, 2025 Walmart launch pricing, cut in December 2025.

Can I pick up LillyDirect Zepbound pricing at Walmart?

Yes. On October 29, 2025 Lilly and Walmart launched the first retail pickup option for LillyDirect self-pay Zepbound, with identical pricing for home delivery and in-store pickup, initially at $349 and $499 and since December 2025 at $299, $399 and $449 by dose. GoodRx (May 18, 2026) also lists the $299 KwikPen manufacturer offer at Walgreens, CVS, Walmart, Costco, Sam's Club and Target. The 45-day refill rule applies in every channel.

Related guides

• Lilly Direct Zepbound Pricing: How the $349 Vial Program Actually Works
• How Much Is Zepbound With Insurance in 2026? The Complete Cost Breakdown
• How Much Is Zepbound Out of Pocket in 2026? The Real Cost Breakdown
• How Much Does Zepbound Cost in Canada in 2026: Provincial Coverage, Private Insurance, and Cross-Border Alternatives
• How Much Does Wegovy Cost in 2026? Cash Price, Insurance Copay Ranges, and Cheaper Alternatives
• How Much Does Metformin Cost in 2026?
• Tool: dosage calculator

Sources

1. Eli Lilly. LillyDirect Zepbound self-pay pricing, seen September 4, 2026. https://www.lilly.com/lillydirect/zepbound
2. U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. FDA.gov. 2024.
3. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022 (SURMOUNT-1).
4. Aronne LJ et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity. JAMA. 2024 (SURMOUNT-4).
5. Malhotra A et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. New England Journal of Medicine. 2024 (SURMOUNT-OSA).
6. Centers for Medicare and Medicaid Services. Medicare GLP-1 Bridge, information for providers, last updated August 6, 2026. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-providers
7. Eli Lilly. Zepbound coverage and savings (savings card terms), seen September 4, 2026. https://zepbound.lilly.com/coverage-savings
8. Kaiser Family Foundation. Employer Health Benefits Survey 2025. GLP-1 coverage section.
9. American Society for Metabolic and Bariatric Surgery. GLP-1 prescribing trends and access. 2025.
10. USP. Standards for Compounded Sterile Preparations (USP 797). 2023.
11. GoodRx. How much does Zepbound cost without insurance?, updated May 18, 2026. https://www.goodrx.com/zepbound/weight-loss-tirzepatide-cost
12. Eli Lilly. LillyDirect Zepbound self-pay pricing ($299, $399, $449 with a refill within 45 days; otherwise $499 or $699), seen September 4, 2026. https://www.lilly.com/lillydirect/zepbound
13. Eli Lilly. Zepbound coverage and savings (savings card $25 with $100, $200 and $300 caps, $1,300 a year, 13 fills, through December 31, 2026; $499 when a commercial plan does not cover it), seen September 4, 2026. https://zepbound.lilly.com/coverage-savings
14. GoodRx. How much does Zepbound cost without insurance? (list $499 to $1,086; average retail $1,291.34 for single-dose pens and $599.85 for KwikPens and vials; $299 KwikPen offer), updated May 18, 2026. https://www.goodrx.com/zepbound/weight-loss-tirzepatide-cost
15. Honest Care. LillyDirect Zepbound pricing (beyond-45-day prices by dose), April 2026. https://www.findhonestcare.com/treatments/zepbound/cost/lillydirect/
16. WeightWatchers. Zepbound through WeightWatchers Med+ (LillyDirect price ladder and beyond-45-day prices), seen September 5, 2026. https://www.weightwatchers.com/us/weight-loss-medication/zepbound
17. Walmart. LillyDirect and Walmart Pharmacy launch first retail pickup option with direct-to-consumer pricing for Zepbound, October 29, 2025. https://corporate.walmart.com/news/2025/10/29/lillydirect-and-walmart-pharmacy-launch-first-retail-pick-up-option-with-direct-to-consumer-pricing-for-zepbound
18. Ro. Zepbound cost with and without insurance (list $499 to $1,086.37; Costco $1,078.79), updated June 26, 2026. https://ro.co/weight-loss/zepbound-cost-with-and-without-insurance/
19. Centers for Medicare and Medicaid Services. Medicare GLP-1 Bridge: information for providers (July 1, 2026 to December 31, 2027; Wegovy, Zepbound KwikPen, Foundayo; BMI criteria; 72-hour decisions), last updated August 6, 2026. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-providers
20. Eli Lilly. Zepbound and the Medicare GLP-1 Bridge ($50 a month for the KwikPen; prior authorization at first fill), seen September 5, 2026. https://zepbound.lilly.com/medicare
21. UnitedHealthcare. Pharmacy prior authorization notification: weight loss (Wegovy, Zepbound, Contrave and others), effective September 1, 2026. https://www.uhcprovider.com/content/dam/provider/docs/public/prior-auth/drugs-pharmacy/commercial/r-z/PA-Notification-Weight-Loss.pdf
22. U.S. Food and Drug Administration. FDA approves first medication for obstructive sleep apnea (Zepbound), December 20, 2024. https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea
23. Eli Lilly. Mounjaro savings and coverage (list price $1,112.16 per fill; savings card $25 with $150, $300 and $450 caps, $1,950 a year, 13 fills, through December 31, 2026), seen September 4, 2026. https://mounjaro.lilly.com/savings-coverage
24. Novo Nordisk. What to pay for Wegovy (self-pay pen $199 for the first two fills then $349, Wegovy HD $399, pill $149, $199, $299; savings card $25 with $100 monthly maximum), seen September 4, 2026. https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html
25. HHS Office of the Assistant Secretary for Planning and Evaluation. 2026 poverty guidelines (400 percent of the guideline is $63,840 for one person). https://aspe.hhs.gov/poverty-guidelines
26. FormBlends. Compounded GLP-1 Price Index methodology and current medians, data as of September 3, 2026. https://formblends.com/report/data/compounded-glp1-price-index
27. U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss (adverse-event report counts as of May 31, 2026). https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

Footer disclaimers

Platform Disclaimer. FormBlends operates as a digital health platform; we connect patients with independent licensed providers and partnered pharmacies. We are not the prescriber, the dispensing pharmacy, or the manufacturer of any medication referenced.

Compounded Medication Notice. References to compounded tirzepatide describe products prepared by 503A state-licensed compounding pharmacies in response to specific prescriptions. Compounded preparations are not FDA-approved, have not undergone the FDA's drug review process, and are not generic equivalents to Zepbound.

Results Disclaimer. Dollar figures and program terms cited reflect public information available on September 4 and 5, 2026. Manufacturer pricing programs, formulary coverage, and patient assistance criteria update on their own schedules. Verify current numbers with the manufacturer or pharmacy before relying on any figure here.

Trademark Notice. Zepbound, Mounjaro, Lilly Direct, and Lilly Cares are registered trademarks of Eli Lilly and Company. Wegovy, Ozempic, and Saxenda are registered trademarks of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by either manufacturer.